221 related articles for article (PubMed ID: 35237235)
1. Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes.
Phimphilai M; Pothacharoen P; Chattipakorn N; Kongtawelert P
Front Endocrinol (Lausanne); 2022; 13():799872. PubMed ID: 35237235
[TBL] [Abstract][Full Text] [Related]
2. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P
Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
[TBL] [Abstract][Full Text] [Related]
3. Impaired osteogenic differentiation and enhanced cellular receptor of advanced glycation end products sensitivity in patients with type 2 diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P; Chattipakorn N
J Bone Miner Metab; 2017 Nov; 35(6):631-641. PubMed ID: 27873077
[TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal - an advanced glycation end products (AGEs) precursor - Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE).
Waqas K; Muller M; Koedam M; El Kadi Y; Zillikens MC; van der Eerden BCJ
Bone; 2022 Nov; 164():116526. PubMed ID: 35995334
[TBL] [Abstract][Full Text] [Related]
5. The trajectory of osteoblast progenitor cells in patients with type 2 diabetes and the predictive model for their osteogenic differentiation ability.
Phimphilai M; Pothacharoen P; Chattipakorn N; Kongtawelert P
Sci Rep; 2023 Feb; 13(1):2338. PubMed ID: 36759556
[TBL] [Abstract][Full Text] [Related]
6. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
[TBL] [Abstract][Full Text] [Related]
8. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
Ragavi R; Adole PS; Vinod KV; Pillai AA
Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
[TBL] [Abstract][Full Text] [Related]
10. Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway.
Zhang M; Li Y; Rao P; Huang K; Luo D; Cai X; Xiao J
Cell Prolif; 2018 Oct; 51(5):e12471. PubMed ID: 30014569
[TBL] [Abstract][Full Text] [Related]
11. Serum AGEs and sRAGE levels are not related to vascular complications in patients with prediabetes.
Gateva AT; Assyov YS; Tsakova AD; Kamenov ZA
Diabetes Metab Syndr; 2019; 13(2):1005-1010. PubMed ID: 31336435
[TBL] [Abstract][Full Text] [Related]
12.
López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications.
Felicetti F; Aimaretti E; Dal Bello F; Gatti F; Godono A; Saba F; Einaudi G; Collino M; Fagioli F; Aragno M; Brignardello E
Free Radic Biol Med; 2022 Jan; 178():76-82. PubMed ID: 34856327
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
15. Advanced Glycation End Products, Diabetes, and Bone Strength.
Yamamoto M; Sugimoto T
Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
[TBL] [Abstract][Full Text] [Related]
16. Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study.
Linkens AMA; Eussen SJMP; Houben AJHM; Mari A; Dagnelie PC; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2023 Aug; 42(8):1491-1500. PubMed ID: 37302878
[TBL] [Abstract][Full Text] [Related]
17. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products inhibit the osteogenic differentiation potential of adipose-derived stem cells by modulating Wnt/β-catenin signalling pathway via DNA methylation.
Li Y; Wang L; Zhang M; Huang K; Yao Z; Rao P; Cai X; Xiao J
Cell Prolif; 2020 Jun; 53(6):e12834. PubMed ID: 32468637
[TBL] [Abstract][Full Text] [Related]
20. Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.
Karim L; Moulton J; Van Vliet M; Velie K; Robbins A; Malekipour F; Abdeen A; Ayres D; Bouxsein ML
Bone; 2018 Sep; 114():32-39. PubMed ID: 29857063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
